http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103191054-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93e2e6da66cc9635384983188986a73c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate | 2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f44cf492dc043d1baf559fa73440bd9 |
publicationDate | 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103191054-B |
titleOfInvention | Heparin sodium tube sealing injection and preparation method thereof |
abstract | The invention provides heparin sodium tube sealing injection, comprising heparin sodium, glucose, mannitol, sodium dihydrogen phosphate, disodium hydrogen phosphate and the balance of water, wherein the tube sealing injection of which the volume is 5ml or 10ml, the osmotic pressure is 260-320 mOsmol/Kg, and the pH value is 6-7 is prepared. By adopting the isotonic injection with low concentration, large volume and stability disclosed by the invention, untoward effects such as local irritation and haemorrhage caused by injection are reduced; the local blood coagulation and tube jamming phenomena are avoided; the anaphylaxis which can be generated by heparin sodium is reduced; meanwhile, the stability of the injection is increased; the sterile level is higher; a plurality of defects in the prior art are solved; and the security of the heparin sodium injection is greatly improved. |
priorityDate | 2013-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.